Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2007
02/01/2007US20070027147 Biarylurea derivatives
02/01/2007US20070027142 Synthesis of vabicaserin, vabicaserin hydrochloride and derivatives by reacting by reacting a 2,3,3A,4,5,9b-hexahydro-1H-cyclopenta(c)quinoline with a chiralagent, 2-methyl-2-oxazoline; decyclization; alkylation; blocking and deblocking; 5-HT2C agonism; schiophrenia
02/01/2007US20070027138 Derivatives and analogs of galanthamine
02/01/2007US20070027137 Analgesic action and antihyperalgesic action; treatment of cognitive deficits, and of various types of pain; Alzheimer's disease, dementia; 1-Phenyl-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione; 1-Benzyl-tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione
02/01/2007US20070027133 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
02/01/2007US20070027114 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate
02/01/2007US20070026407 Novel fine fluorescent particle
02/01/2007US20070022903 Having unsubstituted sulfamoyl group(s) and substituted sulfamoyl group has a substituted triazinyl group; light fastness, ozone fastness and moisture fastness
02/01/2007CA2617042A1 Spiro-cyclic compound
02/01/2007CA2615989A1 Introverted cucurbituril compounds
02/01/2007CA2615946A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors
02/01/2007CA2615581A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
01/2007
01/31/2007EP1747218A2 Neuropeptide receptor modulators
01/31/2007EP1747206A1 Amino-tetrazoles analogues and methods of use
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747021A2 Self-immolative linkers and drug conjugates
01/31/2007EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
01/31/2007CN1906199A Diazaindole-dicarbonyl-piperazinyl antiviral agents
01/31/2007CN1906198A Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
01/31/2007CN1906197A Two-phase method for the synthesis of selected pyrazolopyrimidines
01/31/2007CN1906195A 2,4-dioxopyrimidine-based mesoionic pigments
01/31/2007CN1906189A 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders
01/31/2007CN1906183A N-acylsulfonamide apoptosis promoters
01/31/2007CN1906177A Process for the preparation of pyridopyrimidones
01/31/2007CN1906172A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
01/31/2007CN1906167A Novel pyridine derivative and pyrimidine derivative (2)
01/31/2007CN1906166A Novel pyridine derivative and pyrimidine derivative (1)
01/31/2007CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
01/31/2007CN1905873A Bicyclic inhibitors of MEK and methods of use thereof
01/31/2007CN1905793A 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
01/31/2007CN1903855A Preparation method of unsym-substituted mcso tetraaryl porphyrin kind compound
01/31/2007CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169957 Substantially spherical supramolecular assemblies
01/30/2007US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
01/30/2007US7169918 chemical intermediates used to prepare nucleosides, useful in treating viral infections caused by flaviviruses, such as hepatitis virus
01/30/2007US7169802 Fused pyrrolocarbazoles
01/30/2007US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders
01/30/2007US7169794 Oxidation of a chemical intermediate
01/30/2007US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
01/30/2007US7169784 Medical devices employing triazine compounds and compositions thereof
01/30/2007US7169779 Inhibitors of p38
01/30/2007US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification
01/30/2007US7169378 Delivery of opioids through an inhalation route
01/30/2007CA2307551C Pleuromutilin derivatives as antimicrobials
01/30/2007CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
01/30/2007CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands
01/25/2007WO2007011820A2 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
01/25/2007WO2007009883A1 Novel heteroaryl fused cyclic amines
01/25/2007WO2007009773A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors
01/25/2007WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
01/25/2007WO2006127368A3 Methods for synthesizing imidazotriazinones
01/25/2007WO2006089298A3 Pyrimidine-fused diazepine derivatives and indole-fused pteridines
01/25/2007WO2006033005A3 Thrombopoietin receptor agonists
01/25/2007US20070021587 Polymerization of aromatic monomers using derivatives of hematin
01/25/2007US20070021445 Pyridopyrimidine protein tyrosine phosphatase inhibitors
01/25/2007US20070021442 HIV reverse transcriptase inhibitors
01/25/2007US20070021431 Reverse-turn mimetics and method relating thereto
01/25/2007US20070021430 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
01/25/2007US20070021429 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
01/25/2007US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases
01/25/2007US20070021425 1-(Phenylmethylaminocarbonyl-),4,7-di(oxo-),6-(4-(hydroxylphenyl),8-(piperidino(1,3-phenylene)methyl)-perhydro(pyrazino(2,1-c)-as-triazine); disorders modulated by Wnt-signaling pathway; anticarcinogenic agents; colorectal cancer; restenosis; polycystic kidney disease; angiogenesis inhibition
01/25/2007US20070021408 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
01/25/2007CA2615433A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors
01/25/2007CA2615403A1 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
01/25/2007CA2615381A1 Synergistic composition and method for inhibiting growth of microorganisms
01/25/2007CA2614401A1 Novel heteroaryl fused cyclic amines
01/24/2007EP1746100A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof
01/24/2007EP1746099A1 Mnk1 or Mnk2 inhibitors
01/24/2007EP1746096A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer
01/24/2007EP1745052A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
01/24/2007EP1745047A1 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosine-a2a- receptor antagonists
01/24/2007EP1745046A2 1 h-indazoles, benzothiazoles, 1,2-benziosoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
01/24/2007EP1664053B1 Substituted heterocyclic compounds and methods of use
01/24/2007EP1180028B1 Il-8 receptor antagonists
01/24/2007CN1902761A 有机薄膜晶体管 The organic thin film transistor
01/24/2007CN1902205A Method for preparing phthalocyanines
01/24/2007CN1902204A 烟碱性乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands
01/24/2007CN1902196A Thiazole derivative
01/24/2007CN1902193A Quinoxalines useful as inhibitors of protein kinases
01/24/2007CN1902171A Benzylether amine compounds useful as CCR-5 antagonists
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
01/24/2007CN1900084A Organic silicone porphyrin derivative and its preparing method
01/24/2007CN1900079A New imidazole derivative, method for producing the same and use of the same
01/24/2007CN1296372C A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
01/23/2007US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides
01/23/2007US7166641 Diclofenac salt of lidocaine
01/23/2007US7166602 Anticancer agents; antiinflammatory agents; antiarthritic agents; viricides; central nervous system disorders; Alzheimer's disease; cardiovascular disorders; fungicides
01/23/2007US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/23/2007US7166588 Derivatives and analogs of galanthamine
01/23/2007US7166586 Sulfonamide lactam inhibitors of FXa and method
01/23/2007US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
01/23/2007CA2288045C A new class of benzoporphyrin derivative photoactive compounds
01/23/2007CA2266519C Pyrimidine derivatives and processes for the preparation thereof
01/23/2007CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
01/23/2007CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof
01/18/2007WO2007009101A2 Tetraazaporphyrin-based compounds and their uses
01/18/2007WO2007007069A1 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
01/18/2007WO2007006807A1 New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against uv radiation